Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency
Clinical trial NCT06120972 · WITHDRAWN
Trial details
- NCT number
- NCT06120972
- Sponsor
- Alexander B Olawaiye, MD
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-17
- Primary completion
- 2027-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.